About this trial
This monocentric observational study aims to evaluate the association between plasma vitamin C levels (ascorbemia) and the presence of osteoporotic vertebral fractures in patients with osteoporosis. Forty participants will be enrolled at the Rheumatology
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men aged 50 yars or older ;
Postmenopausal women ;
Afilliated with a health insurance and system ;
Written informed consent obtained.
Disqualifiers
Legal protection measure (guardianship, curatorship);
inability to provide informed consent ;
refusal to participate ;
Vertebral fracture related to tumor,
Trial design
Parallel
Treatments tested in this trial
Plasma vitamin C assessment
Diagnostic testBlood sampling for measurement of plasma vitamin C concentration (ascorbemia) in patient of the study
Treatment groups
Trial outcomes
Primary outcomes
Plasma vitamin C concentration
Comparison of plasma vitamin C concentration (ascorbemia, µmol/L) between patients with osteoporotic vertebral fractures and patients with osteoporosis without vertebral fracture.
Secondary outcomes
Association between plasma vitamin C level and number of vertebral fractures
Assessment of the relationship between plasma vitamin C concentration and the number of osteoporotic vertebral fractures
Association between plasma vitamin C level and lumbar bone mineral density
Assessment of the relationship between plasma vitamin C concentration and lumbar spine bone mineral density measured by DXA.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: